D. Hatseras

发表

AORTIC ARCH CALCIFICATION PREDICTS THE EXTENT OF CORONARY ATHEROSCLEROSIS IN PATIENTS WITH OR WITHOUT TYPE 2 DIABETES: SHORT COMMUNICATION

E. Maltezos, D. Stakos, D. Tziakas, 2007, Acta clinica Belgica.

Peripheral Arterial Occlusive Disease as a Predictor of the Extent of Coronary Atherosclerosis in Patients with Coronary Artery Disease with and without Diabetes Mellitus

E. Maltezos, D. Tziakas, G. Louridas, 2004, The Journal of international medical research.

The contrOL of dYslipideMia in outPatIent clinics in GreeCe (Olympic) Study

P. Vardas, A. Manolis, V. Athyros, 2005, Angiology.

Alteplase treatment affects circulating matrix metalloproteinase concentrations in patients with ST segment elevation acute myocardial infarction.

J. Kaski, I. Tentes, D. Stakos, 2006, Thrombosis research.

The potential of D-dimer levels as a useful clinical marker of clotting state after the return of sinus rhythm.

D. Hatseras, E. Hatzinikolaou-Kotsakou, 2006, Future cardiology.

Clotting state after cardioversion of atrial fibrillation: a haemostasis index could detect the relationship with the arrhythmia duration

D. Stakos, D. Tziakas, G. Chalikias, 2005, Thrombosis journal.

N-terminal pro-B-type natriuretic peptide and matrix metalloproteinases in early and late left ventricular remodeling after acute myocardial infarction.

J. Kaski, I. Tentes, D. Stakos, 2005, The American journal of cardiology.

IMPACT OF DIABETES MELLITUS ON SEVERITY OF CONCOMITANT PERIPHERAL ARTERIAL OCCLUSIVE DISEASE IN PATIENTS WITH CORONARY ARTERY DISEASE

E. Maltezos, D. Tziakas, G. Louridas, 2005, Acta clinica Belgica.

Could sustained monomorphic ventricular tachycardia in the early phase of a prime acute myocardial infarction affect patient outcome?

E. Maltezos, D. Stakos, D. Tziakas, 2007, Journal of electrocardiology.

Relation of C-reactive protein to the first onset and the recurrence rate in lone atrial fibrillation.

E. Maltezos, D. Stakos, D. Tziakas, 2006, The American journal of cardiology.

Nebivolol Increases Atrial Natriuretic Peptide/Systolic Blood Pressure Ratio in Hypertensive Patients

M. Karamouzis, D. Hatseras, I. Vogiatzis, 2008 .

Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3.

D. Stakos, D. Tziakas, G. Chalikias, 2004, European cytokine network.

Effects of Helicobacter pylori infection on gastric emptying rate in patients with non-ulcer dyspepsia.

E. Maltezos, G. I. Leontiadis, G. Minopoulos, 2004, World journal of gastroenterology.

Inflammatory and anti-inflammatory variable clusters and risk prediction in acute coronary syndrome patients: a factor analysis approach.

J. Kaski, I. Tentes, D. Stakos, 2007, Atherosclerosis.

Total cholesterol content of erythrocyte membranes is increased in patients with acute coronary syndrome: a new marker of clinical instability?

J. Kaski, I. Tentes, D. Tziakas, 2007, Journal of the American College of Cardiology.

Interleukin-18: interleukin-10 ratio and in-hospital adverse events in patients with acute coronary syndrome.

J. Kaski, I. Tentes, D. Stakos, 2005, Atherosclerosis.

Detection of Mycobacterium tuberculosis complex DNA in pericardial fluid, bone marrow and peripheral blood in a patient with pericardial tuberculosis. A case report.

D. Stakos, K. Ritis, D. Hatseras, 2001, Netherlands Journal of Medicine.

Anti-inflammatory cytokine profile in acute coronary syndromes: behavior of interleukin-10 in association with serum metalloproteinases and proinflammatory cytokines.

I. Tentes, D. Tziakas, G. Chalikias, 2003, International journal of cardiology.

Apolipoprotein E genotype and circulating interleukin-10 levels in patients with stable and unstable coronary artery disease.

J. Kaski, I. Tentes, D. Tziakas, 2006, Journal of the American College of Cardiology.

Coronary Artery Disease polipoprotein E Genotype and irculating Interleukin-10 Levels in Patients ith Stable and Unstable Coronary Artery Disease

J. Kaski, I. Tentes, G. Chalikias, 2006 .

Revisiting the frequency of peripheral arterial disease in patients with coronary artery disease: is there a difference between diabetic and non-diabetic patients?

E. Maltezos, D. Tziakas, G. Louridas, 2006, VASA. Zeitschrift fur Gefasskrankheiten.

Levosimendan Use Reduces Matrix Metalloproteinase-2 in Patients with Decompensated Heart Failure

E. Maltezos, J. Kaski, I. Tentes, 2005, Cardiovascular Drugs and Therapy.

Comparison of levels of matrix metalloproteinase-2 and -3 in patients with ischemic cardiomyopathy versus nonischemic cardiomyopathy.

E. Maltezos, I. Tentes, D. Stakos, 2005, The American journal of cardiology.

Gliclazide treatment lowers serum ICAM-1 levels in poorly controlled type 2 diabetic patients.

E. Maltezos, D. Tziakas, N. Papanas, 2006, Diabetes & metabolism.

Gelatinases [Matrix Metalloproteinase-2 (MMP-2) and MMP-9] Induce Carotid Plaque Instability But Their Systemic Levels Are Not Predictive of Local Events

I. Tentes, D. Tziakas, G. Georgiadis, 2005, Annals of vascular surgery.

Interleukin-18/interleukin-10 ratio is an independent predictor of recurrent coronary events during a 1-year follow-up in patients with acute coronary syndrome.

J. Kaski, I. Tentes, D. Stakos, 2007, International journal of cardiology.

Atrial Fibrillation and Hypercoagulability: Dependent on Clinical Factors or/and on Genetic Alterations?

D. Stakos, D. Tziakas, G. Bourikas, 2003, Journal of Thrombosis and Thrombolysis.